Evidence map›Paper›PMID 35854129›Full record

ArticleJournal of molecular modeling2022

Study of protease-mediated processes initiating viral infection and cell-cell viral spreading of SARS-CoV-2.

Thanawat Thaingtamtanha, Stephan A Baeurle

Open access · hybridAbstract read
In one paragraph

Article in Journal of molecular modeling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. SARS-CoV-2 and natural infection in animals.Journal of medical virology · 2023
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Thanawat ThaingtamtanhaDepartment of Chemistry and Biology, Universität Siegen, Adolf-Reichwein-Str. 2, 57076, Siegen, Germany.
Stephan A BaeurleDepartment of Chemistry and Biology, Universität Siegen, Adolf-Reichwein-Str. 2, 57076, Siegen, Germany. Stephan.Baeurle@uni-siegen.de.ORCID http://orcid.org/0000-0001-7565-0997
University of Siegen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral-cell entry and cell-cell viral spreading processes of SARS-CoV-2 are subjected to fast evolutionary optimization because of its worldwide spreading, requiring the need for new drug developments. However, this task is still challenging, because a detailed understanding of the underlying molecular processes, mediated by the key cellular proteases TMPRSS2 and furin, is still lacking. Here, we show by large-scale atomistic calculations that binding of the ACE2 cell receptor at one of the heteromers of the SARS-CoV-2 spike leads to a release of its furin cleavage site (S1/S2), enabling an enhanced furin binding, and that this latter process promotes the binding of TMPRSS2 through the release of the TMPRSS2 cleavage site (S2') out of the ACE2-binding heteromer. Moreover, we find that, after proteolytic cleavage, improved furin binding causes that parts of the S2 subunit dissociate from the complex, suggesting that furin promotes the fusion of the S2 subunit with the cell membrane before transfer of the viral RNA. Here we show by computational means that binding of the ACE2-cell receptor at one of the heteromers of the SARS-CoV-2 spike leads to an enhanced binding of the protease furin, promoting the binding of the protease TMPRSS2. Moreover, we show that, after proteolytic cleavage, improved furin binding causes that parts of the heteromer dissociate from the spike.

Indexed as

COVID-19SARS-CoV-2Angiotensin-Converting Enzyme 2FurinHumansPeptide HydrolasesSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2FurinPeptide HydrolasesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Cell–cell viral spreadingFurin cleavageSARS-CoV-2TMPRSS2 cleavageViral-cell entry

Identifiers

PMID35854129
PMCPMC9296015
OpenAlexW4285798671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.